China Plans National Flu-Monitoring System For Vaccination Prep
This article was originally published in PharmAsia News
Executive Summary
Chinese authorities are planning a nationwide monitoring system to track the incidents of influenza and be prepared for vaccinating the public. One official said only 1.5 percent of the Chinese receive an annual flu vaccine, compared with more than 20 percent in most developed countries. The World Health Organization has encouraged wider use of flu vaccines in China because of the frequency of mutations and high infection rates. A national monitoring system would help the country discover the latest mutations of the flu virus, a WHO official said. (Click here for more
You may also be interested in...
Second EU MDR Notified Body Designated In France
Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.
Takeda, Astellas Found New JV To Support Japanese Bioventures
Major Japanese companies Takeda, Astellas and SMBC are joining hands to establish a new joint venture with $3.9m capital and based in Japan’s largest biocluster Shonan iPark to help incubate local biopharma start-ups.
Could Eledon’s Anti-CD40L Change Transplant Medicine?
Eledon Pharmaceuticals’ CD40 Ligand blocker has yielded impressive results for post-transplant immunosuppression and cutting-edge transplant doctors have also used it for pig-to-human kidney and heart transplants, opening up the field of xenotransplantation.